Spotlight of the month: Unified Patent Court captures 15% of European patent litigation but still far from being primary European patent court
Changes to the proposed new medicinal products Directive have been approved by the EU Parliament – do they shift the balance between generics and innovators and are they TRIPS compliant?
Mathys & Squire files Petition for Review for Ipsen Bioinnovation
Mathys & Squire recognised as one of Europe’s leading patent firms in the Financial Times 2024 rankings
Fifteen Mathys & Squire attorneys recognised in IAM Patent 1000 2024
Spotlight of the month: MS-RT launches its new range of innovative sport-inspired Ford vehicle designs with the all-new Ford Ranger MS-RT and Transit Custom MS-RT
The supermarket battle continues: Tesco and Lidl clash in UK Court of Appeal
Beyond misconceptions: Exploring the patentability and challenges associated with AI-driven bioinformatics innovations in Europe
Where next for patentability of AI inventions in the UK?
A further blow to transparency at the UPC
Mathys Matters January 2024
In this edition:
Spotlight of the month: UPC Court of Appeal interprets law narrowly in transparency test case
EPO announces fee increases from 1 April 2024
UK banks lag behind US banks in innovation – only 290 patents filed in the last decade
How do opposition rates impact opt-outs?
Mathys & Squire patent team and four Partners recognised in JUVE Patent UK rankings for 2024.
Sign up to Mathys Matters, our monthly newsletter, to receive all the latest insights, expert analysis, and key updates on intellectual property and sector developments, delivered directly to your inbox.